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Human Papillomavirus
Lauren Leathers BSN, RN, C-EFM, CCE
IntroductionHuman	Papillomavirus	(HPV)	is	the	most	common	sexually	transmitted	infection	(STI)	across	the	United	States	with	approximately	42.5%	of	Americans	aged	18-59	infected	with	the	virus	 and	approximately	14	million	new	cases of HPV each year(CDC,	2017).	Numerous variations	ofthis	disease	exist,	leading	to	diverse	symptoms	and	reactions.	Depending	on	the	strain,	HPV	can	remain	labile	or	transient	for	those	infected;	however,	other	strains	of	HPV	can	lead	to	lifelong	consequences	as	great	as	death	in	some	patients	(Mirabello et	al,	2018).	Approximately	485,000	cases	of	cervical	cancer	related	to	high-risk	HPV	strains	were	diagnosed	globally	in	2008;	236,000	of	these	cervical	cancer	patients	died	that	same	year	(Mirabello et	al,	2018).	There	is	a	vaccination	to	protect	patients	from	four	of	the	major	high-risk	cancer	or	genital	wart	causing	strains	of	HPV,	but	completion	of	this	vaccination	series	across	individuals	in	the	United	States	is	lower	than	anticipated.	Healthy	People	2020	includes	a	goal	of	80%	of	all	males	and	females	between	the	ages	of	13-15	complete	the	HPV	vaccination	series	(ODPHP,	2018).	However,	as	of	2015,	only	42	percent	of	girls	and	28	percent	of	boys	in	this	age	group	have	been	administered	all	three	doses	of	this	series	(CDC,	2017).	Due	to	its	virality	and	prevention	capability,	HPV	is	a	hot	topic	of	interest	amongst	health	providers	that	continues	to	be	explored.	
References:
▸ HPV	is	contracted through direct skin to	skin	contact	in	both	males	and	females	(CDC,	2016).	
▸ Transmission	is	typically	from	oral,	vaginal	or	anal sexual activity	(CDC,	2016).
▸ Increased likelihood	of	infection	can	occur	due	to:	promiscuity,	having	sexual	contact	with	an	individual	who	has	had	multiple	sex	partners,	initiation	of	sexual	activity		at	an	early	age,	and	lack	of	circumcision	(Rigaud,	2015).		
▸ Over	200	forms	of	HPV	have been identified(Mirabello et al, 2018).	
▸ Amongst	these	types,	HPV	is	classified	into	”high”	or	“low”	risk	categories	based	on	the	ability	to	become	cancerous	(Soto,	Song,	&	McLaughlin-Drubin,	2017).	
▸ High-risk	strains	are	often	persistent	and	can	lead	to	genital,	anal	or	oral	cancers	(Soto	et	al,	2017).
▸ The more	typical	carcinogenic	variations	of	HPV	include	high	risk	strains,	such	as	HPV	16	and	18 (Crosignani et	al,	2013).	
▸ Low	risk	HPVs	are	typically	transient	or	cause	little to	no	symptoms	(Crosignani et	al,	2013).
▸ Low risk strains	such	as	HPV	6	and	11	mayalso	cause	minor	symptoms	such	as	genital	warts	(Crosignani et	al,	2013).
▸ Many individuals do not know they haveHPV	(Rigaud,	2015).
▸ Approximately	70%	of	HPV	infections	are	cleared	within	one	year,	and	90%	of	infections	are	cleared	at	2	years	(Rigaud,	2015).	
▸ Often	cervical	diagnosis	of	HPV	occurs	through	routine	cervical	cytology	testing,	or	a	Pap	smear,	in	women.	Otherwise,	HPV	may	not	be	identified	until	cancerous	lesions	or	warts	are	found	(Rigaud,	2015).	
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Signs and Symptoms
Transmission Underlying	Pathophysiology
▸ Human	Papillomaviruses	are	microscopic,	DNA	pathogens	that	invade	the	body	through	small	tears	or	abrasions	in	epithelial	tissue	such	as	the	cervix,	oropharynx,	and	skin	(Crosignani et al,	2013).	
▸ HPV	cells	infect	basal	keratinocytes	located	in	the	basement	layer	of	the	tissue’s	stratified	squamous	epithelium	(Crosignani et al,	2013).	
▸ E6	and	E7	oncogenes	found	within	these	HPV	cells	disrupt	the	normal	function	of	cellular	p53	and	retinoblastoma	proteins,	leading	to	increased	production	of	abnormal	basal	cells	(Soto	et	al,	2017).	
▸ Continued	replication	of	HPV	infected	basal	cells	leads	to	disorganization	in	the	epithelial	structure	as	these	cells	continue	to	proliferate	and	mature	(Mirabello et	al,	2018).	
▸ For	most	individuals,	the	body	interrupts	such	an	HPV	infection	through	immune	system	recognition	and		intervention.		HPV	infections	can	be	eliminated	within	2	years	of	exposure	(Rigaud,	2015).	
▸ However,	persistent	HPV	infection	can	lead	to	more	critical,	carcinogenic	results	(Crosignani et	al,	2013).	
Significance
▸ High	risk HPVs are known to causeapproximately	5%	of	all	human	cancers	(Soto	et	al,	2017).	
▸ American men and women arediagnosed with approximately 33.369HPV related cancers	each	year	(Crosignani et al, 2013).	
▸ HPV	is	also	now	known	as	the	direct	cause	for	greater	than	95%	of	all	cervical	cancer	cases,	the	3rd	leading	cancer	amongst	women	(Mirabello et	al,	2018).	
▸ HPV	carcinogenic	lesion	progression	is	slow.	Cancerous	lesions	may	not	be	symptomatic	or	identified	until	10-15	years	following	initial	infection	(Crosignani et al,	2013).	
▸ Without early detection	and	intervention,	cancerous	lesions	resulting	from	HPV	infection	may	be	lethal	in	some	patients	(Mirabello et	al,	2018).
Nursing	Implications
▸ As healthcare	providers,	HPV	prevention	can	be	facilitated	through	regular	screening,	patient	education	and	vaccination.	
▸ Screening	done	through	cervical	Pap	smears	are	recommended	every	3	years	for	women	aged	21-65	(Rigaud,	2015).
▸ Musa et al found that women	exposed	to	HPV	education	were	2.5	times	more	likely	to	attend	routine Pap smears forcervical	disease	screening	(2017).	
▸ A	vaccination	series called “Gardasil	9”	exists	to	prevent	9	of	the	most	common	high	risk	and	genital	wart	causing	HPV	strains.	This	series	is	either	2	or	3	steps	depending	on	age	initiation	(Merck	Sharp	&	Dohme	Corp.,	2017).	
▸ Initiating the HPV vaccination at an	early	age	prior	to	sexual	contact	is	key	to	prevent	HPV	infection.	Gardasil	9	may	be	administered	from	ages	9-26	(Merck	Sharpe	&	Dohme	Corp.,	2017).	
▸ Population completion	of	the	Gardasil	9	series	has	been	less	than	hoped.	Due	to	issues	such	as	the	complexity	of	the	multi-step	dosing,	low	perceived	risk		and	stigma	of	sexual	intimacy	discussion	for	younger	adolescents,	Garbutt	et	al	finds	challenges	to	Gardasil	administration	(2018).
▸ No cure exists for HPV	infections	(Rigaud,	2015).	
ConclusionsHuman	Papillomavirus	is	a	common	pathogen	affecting	American	people.	Per	the	CDC,	approximately	80	percent	of	all	people	will	have	some	form	of	HPV	during	their	lifetime	(2016).	Though	most	strains	of	HPV	are	temporary and seeminglyharmless,	other	more	virulent	strains	may	cause	complications	such	as	cancer	of	the	cervix,	penis,	anus,	or	oropharynx.		Prevention	and	detection are key.	Education on the disease and vaccination	using	Gardasil	9	are	essential	for	providers	to	implement	amongst	patients,	particularly	parents	and	adolescents.	Continued	screening	through	annual	Pap	smears	are	also	important	for	early	identification	of HPV causing	cervical	cancers	in	women.	
The	photo	above	illustrates	the	HPV infection process at the cellular level (Kahn,	2009).	
